Soon Kim

Do Soon Kim is the Chief Operating Officer (COO) and Head of Product at Inceptive, a biotechnology company focused on developing biological software, particularly in the area of RNA medicines. He has been with Inceptive since September 2021, where he is responsible for business development and product management, collaborating with a talented team to advance their innovative solutions in the biotech field.1

Professional Background

• Education: Do Soon Kim holds a PhD in Chemical and Biological Engineering from Northwestern University, where he conducted research in synthetic biology. He also earned a Bachelor of Science in Chemical Engineering from The University of Texas at Austin.1
• Previous Experience:
  • Before joining Inceptive, he worked as a Research Engineer at Eli Lilly and Company, focusing on RNA medicines.
  • He was a Visiting Research Scientist at Stanford University, where he contributed to mRNA vaccine design and citizen science initiatives.
  • His early career included roles at Genentech and The Boston Consulting Group, along with research positions during his undergraduate studies.1

Personal Interests

Do Soon Kim emphasizes the importance of family in his personal life, striving to be the best father and husband he can be.1 His professional interests lie in leveraging technology for societal benefits, particularly through advancements in RNA therapeutics.